Stock Market News

Kymera Therapeutics stock soars on positive trial results for KT-621

Jun 2, 2025 - 14:46
 0
Kymera Therapeutics stock soars on positive trial results for KT-621
Read More

Tags:

Previous Article

Blade Air Mobility: Fundamentals Continue To Strengthen

Next Article

Tariffs, turmoil, and the VIX: How April 2025 compares to past crises?

Related Posts

China's CATL aims to raise about $4 bln in Hong Kong IPO

May 12, 2025  0

US probes Live Nation, AEG COVID-19 concert cancellations

US probes Live Nation, AEG COVID-19 concert cancellations

May 16, 2025  0

Starbucks shuffles top brass, names new operating chief

Starbucks shuffles top brass, names new operating chief

Jun 5, 2025  0